Your browser doesn't support javascript.
loading
Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma.
Makhlin, Igor; Salinas, Ryan D; Zhang, Daniel; Jacob, Fadi; Ming, Gou-Li; Song, Hongjun; Saxena, Deeksha; Dorsey, Jay F; Nasrallah, MacLean P; Morrissette, Jennifer Jd; Binder, Zev A; O'Rourke, Donald M; Desai, Arati S; Brem, Steven; Bagley, Stephen J.
Afiliación
  • Makhlin I; Division of Hematology & Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Salinas RD; Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Zhang D; Biochemistry & Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Jacob F; Department of Neuroscience & Mahoney Institute for Neurosciences, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Ming GL; The Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Song H; Department of Neuroscience & Mahoney Institute for Neurosciences, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Saxena D; Department of Neuroscience & Mahoney Institute for Neurosciences, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Dorsey JF; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Nasrallah MP; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Morrissette JJ; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Binder ZA; GBM Translational Center of Excellence, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • O'Rourke DM; Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Desai AS; Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Brem S; Center for Personalized Diagnostics, Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Bagley SJ; Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA 19104, USA.
CNS Oncol ; 8(3): CNS43, 2019 11 01.
Article en En | MEDLINE | ID: mdl-31769726
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acrilamidas / Neoplasias Encefálicas / Glioblastoma / Inhibidores de Proteínas Quinasas / Compuestos de Anilina / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans Idioma: En Revista: CNS Oncol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acrilamidas / Neoplasias Encefálicas / Glioblastoma / Inhibidores de Proteínas Quinasas / Compuestos de Anilina / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans Idioma: En Revista: CNS Oncol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos